The ventral hernia treatment market is projected to grow from USD 5.7 billion in 2025 to USD 10.6 billion by 2035, at a CAGR of 6.4%. Epigastric (Stomach Area) Hernia will dominate with a 41.7% market share, while ultrasound will lead the diagnosis segment with a 47.3% share.